PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,6-dichlorohexane | 218-491-7 | 2163-00-0 | - | - | 1 | - | - | - | - | - | - | Details |
|
1,6-hexanediyl-bis(2-(2-(1-ethylpentyl)-3-oxazolidinyl)ethyl)carbamate
HÄRTER VERSUCHSPRODUKT LS 2959E; HÄRTER VP LS 2959E
|
411-700-4 | 140921-24-0 | - | - | 3 | - | - | - | - | - | - | Details |
| 1,8-diazabicyclo[5.4.0]undec-7-ene | 229-713-7 | 6674-22-2 | - | - | 1 | - | - | - | - | - | - | Details |
| 1,8-naphthylenediamine | 207-529-8 | 479-27-6 | - | - | 1 | - | - | - | - | - | - | Details |
| 1-(1-methyl-2-propoxyethoxy)propan-2-ol | 249-949-4 | 29911-27-1 | - | - | 1 | - | - | - | - | - | - | Details |
|
1-(2,6-bis(4-tolyl)-1,3-dioxano(5,4-d)-1,3-dioxan-4-yl)ethane-1,2-diol
CLEARLITE NU 005; DISORBENE M; GENISET MD; GLC NU 005; MILLAD 3940; NU 005
|
402-950-5 | 81541-12-0 | - | - | 1 | - | - | - | - | - | - | Details |
| 1-(2-butoxy-1-methylethoxy)propan-2-ol | 249-951-5 | 29911-28-2 | - | - | 1 | - | - | - | - | - | - | Details |
|
1-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate
PYRAZOL P5; PYRAZOLE DHE
|
429-300-3 | 155601-30-2 | - | - | 1 | - | - | - | - | - | - | Details |
| 1-(2-hydroxyethyl)pyrrolidin-2-one | 222-359-4 | 3445-11-2 | - | - | 2 | - | - | - | - | - | - | Details |
|
1-(4-(2-cloro-α,α,α-p-trifluorotolyloxy)-2-fluorophenyl)-3-(2,6-difluorobenzolyl)urea
FLUFENOXURON
|
417-680-3 | 101463-69-8 | - | - | - | - | - | 1 | - | - | - | Details |